Literature DB >> 2935554

Reduced function of HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE).

F Shirakawa, U Yamashita, H Suzuki.   

Abstract

Accessory function of monocytes for T-cell activation was studied in patients with systemic lupus erythematosus (SLE). Nylon column-purified T cells alone were not activated to proliferate by stimulation with concanavalin A (Con A), but the addition of dish-adherent monocytes restored the T-cell response in a dose-dependent manner (accessory function). This accessory function is mediated by HLA-DR-positive monocytes. This accessory function of monocytes was markedly impaired in SLE patients. The dysfunction of monocytes was marked in an active stage of SLE but not in an inactive stage of SLE. Furthermore, SLE T cells were not fully activated with Con A in the presence of normal monocytes, suggesting that both monocyte and T-cell functions were impaired in SLE patients. The dysfunction of SLE monocytes was due to neither the development of suppressor monocytes nor the overproduction of prostaglandins, because SLE monocytes did not suppress the accessory function of normal monocytes and indomethacin did not restore the dysfunction of SLE monocytes. The percentage of HLA-DR-positive cells in a monocyte population was markedly decreased in active SLE patients and moderately decreased in inactive SLE patients. Thus, the impairment of accessory function of monocytes in SLE patients seems to be derived from a decrease in HLA-DR-positive monocytes. These results suggest that the dysfunction of HLA-DR-positive monocytes plays an important role in the pathogenesis of SLE.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935554     DOI: 10.1007/bf00915337

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  23 in total

1.  The requirement of Ia-positive accessory cells for the induction of hapten-reactive cytotoxic T lymphocytes in vitro.

Authors:  U Yamashita; T Hamaoka
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

2.  The role of monocytes in human lymphocyte activation by mitogens.

Authors:  J E de Vries; A P Caviles; W S Bont; J Mendelsohn
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

3.  Two populations of Ia-like molecules on a human B cell line.

Authors:  L A Lampson; R Levy
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

4.  Increase in macrophage Ia expression in autoimmune mice: role of the Ipr gene.

Authors:  V E Kelley; J B Roths
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

Review 5.  The regulatory role of macrophages in antigenic stimulation. Part Two: symbiotic relationship between lymphocytes and macrophages.

Authors:  E R Unanue
Journal:  Adv Immunol       Date:  1981       Impact factor: 3.543

Review 6.  Autoimmunity--a perspective.

Authors:  H R Smith; A D Steinberg
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

7.  Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus.

Authors:  R M Blaese; J Grayson; A D Steinberg
Journal:  Am J Med       Date:  1980-09       Impact factor: 4.965

8.  Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells.

Authors:  T Sakane; A D Steinberg; I Green
Journal:  Arthritis Rheum       Date:  1978 Jul-Aug

9.  Decrease in HLA-DR-positive monocytes in patients with systemic lupus erythematosus (SLE).

Authors:  F Shirakawa; U Yamashita; H Suzuki
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

10.  Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE).

Authors:  M Linker-Israeli; A C Bakke; R C Kitridou; S Gendler; S Gillis; D A Horwitz
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

View more
  8 in total

Review 1.  Monocyte and macrophage abnormalities in systemic lupus erythematosus.

Authors:  Yi Li; Pui Y Lee; Westley H Reeves
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-07-31       Impact factor: 4.291

2.  Accessory cell activity of monocytes in anti-DNA antibody production in systemic lupus erythematosus.

Authors:  T Sasaki; S Shibata; Y Hirabayashi; Y Sekiguchi; K Yoshinaga
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

3.  Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility.

Authors:  F Steinbach; F Henke; B Krause; B Thiele; G R Burmester; F Hiepe
Journal:  Ann Rheum Dis       Date:  2000-04       Impact factor: 19.103

4.  Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background.

Authors:  S Rashtak; E Marietta; S Cheng; M Camilleri; M Pittelkow; C David; J Grande; J Murray
Journal:  Lupus       Date:  2010-02-08       Impact factor: 2.911

5.  Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus.

Authors:  Y Tanaka; K Watanabe; M Suzuki; K Saito; S Oda; H Suzuki; S Eto; U Yamashita
Journal:  J Clin Immunol       Date:  1989-09       Impact factor: 8.317

6.  Haem oxygenase 1 expression is altered in monocytes from patients with systemic lupus erythematosus.

Authors:  Andrés A Herrada; Carolina Llanos; Juan P Mackern-Oberti; Leandro J Carreño; Carla Henriquez; Roberto S Gómez; Miguel A Gutierrez; Ignacio Anegon; Sergio H Jacobelli; Alexis M Kalergis
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

7.  Monocyte (macrophage)-specific antibodies in patients with systemic lupus erythematosus (SLE).

Authors:  F Shirakawa; U Yamashita; H Suzuki
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

Review 8.  Rheumatoid arthritis and systemic lupus erythematosus: Pathophysiological mechanisms related to innate immune system.

Authors:  Maria Angélica Pabón-Porras; Sebastian Molina-Ríos; Jorge Bruce Flórez-Suárez; Paola Ximena Coral-Alvarado; Paul Méndez-Patarroyo; Gerardo Quintana-López
Journal:  SAGE Open Med       Date:  2019-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.